We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04173507
Brief Title: Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

First Submitted : November 20, 2019
First Submitted that Met QC Criteria : November 20, 2019
First Posted : November 22, 2019

Results First Submitted : October 18, 2022
Results First Posted with QC Comments : November 16, 2022
Results First Submitted that Met QC Criteria : December 14, 2022
Results First Posted : January 9, 2023

Last Update Submitted that Met QC Criteria : December 14, 2022
Last Update Posted : January 9, 2023